Product Focus: Latest RIQAS Programmes
Product Focus: Latest RIQAS Programmes
RIQAS is the largest international External Quality Assessment (EQA)/ Proficiency Testing (PT) scheme, with over 45,000 participants across 32 comprehensive programme options. Providing access to large, international peer groups you can be confident in the statistical validity of the results obtained.
In March 2016, we added eight new RIQAS EQA programmes to our already extensive portfolio. The new programmes included; CSF, Sweat Testing, Immunosuppressant drugs, Trace Elements in Serum, Trace Elements in Urine, Trace Elements in Blood, Anti-TSH Receptor (TRAb) and Cyfra 21-1.
Like all programmes the latest additions are designed to cover the full clinical decision range, reassuring clinicians and patients that the results released are accurate and reliable. The added benefit of monthly reporting supports the rapid identification of errors, this combined with a report turnaround of 24-72 hours from the submission deadline allows faster implementation of any necessary corrective actions, reducing the need for expensive and time consuming patient sample retests.
With Cycle 2 of the new programmes just around the corner we thought we would take this opportunity to explore what each programme has to offer.
Week 1- Trace Elements in Serum, Trace Elements in Urine, Trace Elements in Blood
RIQAS provide three trace element programmes designed for use in clinical and toxicology laboratories specialising in the testing of trace metals, heavy metals and minerals. Options are available for blood, serum and urine ensuring a matrix similar to that of the patient sample. Each programme will help ensure the accuracy of test results in patients who have experienced accidental or occupational exposure to such toxic metals
Main Features and Benefits;
- Lyophilised samples
- Monthly reporting
- Testing covers the full range of clinically relevant decision levels
- Submit results and view reports online via RIQAS.net
- 12 month subscription
Week 2- CYFRA 21-1 & Anti-TSH Receptor
The RIQAS CYFRA 21-1 EQA programme is designed to cover the analysis of the tumour marker CYFRA 21-1 in clinical laboratories when monitoring the response to treatment of cancers such as non-small cell lung carcinoma, cervical, breast and bladder cancer.
Main Features and Benefits;
- Lyophilised samples
- Monthly reporting
- Testing covers the full range of clinically relevant decision levels
- Submit results and view reports online via RIQAS.net
- 12 month subscription
Our dedicated Anti-TSH Receptor EQA programme is designed to supplement our general immunoassay programme by including the thyroid hormone Anti-TSH Receptor also known as TRAb.
Main Features and Benefits;
- Lyophilised samples
- Monthly reporting
- Testing covers the full range of clinically relevant decision levels
- Submit results and view reports online via RIQAS.net
- 12 month subscription
Week 3 – CSF & Sweat Testing
The RIQAS Cerebrospinal Fluid EQA programme has been designed to monitor the performance of several analytes in CSF.
Main Features and Benefits;
- Liquid ready-to-use samples
- Monthly reporting
- Testing covers the full range of clinically relevant decision levels
- Submit results and view reports online via RIQAS.net
- 12 month subscription
The RIQAS Sweat Testing EQA programme has been designed to cover the analysis of Sweat Testing in clinical laboratories measuring the concentration of Chloride, Sodium and Conductivity in sweat, used in the testing of Cystic Fibrosis (CF).
Main Features and Benefits;
- Liquid ready-to-use samples
- Monthly reporting
- Testing covers the full range of clinically relevant decision levels
- Submit results and view reports online via RIQAS.net
- 12 month subscription
Week 4 – RIQAS Immunosuppressant EQA programme
The RIQAS Immunosuppressant Drug EQA programme has been designed to cover the analysis of Cyclosporin, Everolimus, Sirolimus and Tacrolimus in clinical laboratories.
Main Features and Benefits;
- Lyophilised samples
- Monthly reporting
- Testing covers the full range of clinically relevant decision levels
- Submit results and view reports online via RIQAS.net
- 12 month subscription
One RIQAS Haematology Sample
With over 40,000 laboratory participants in 124 countries, RIQAS is truly the largest international External Quality Assessment (EQA) scheme. The large volume of participants is testament to the quality of our material and highlights further the trust and confidence laboratories have in RIQAS to help them accurately report their patient results.
RIQAS is world renowned for delivering flexible EQA solutions to help laboratories reduce the number of programmes required. Our RIQAS portfolio covers most areas of clinical testing including Haematology.
Our RIQAS Haematology programme combines 11 parameters in total and comprises the full blood count into a single sample. Designed with user convenience in mind, samples are supplied in a liquid ready-to-use format in primary tubes. Coupled with user-friendly reports, enabling at-a-glance performance assessment, preparation and evaluation time will be dramatically reduced in even the most demanding of laboratories.
Errors will be identified early thanks to the bi-weekly analysis of the Haematology programme, while reports are ready within a maximum of 72 hours from the date of submission and accreditation to ISO 17043:2010 allows the laboratory to take any necessary corrective actions.
Cat No. Kit Size Frequency Parameters
RQ9118 6 x 2ml Bi-weekly Eleven (11)
Parameters
- Haemoglobin (Hb)
- Mean Cell Volume (MCV)
- Mean Cell Haemoglobin Concentration (MCHC)
- Red Blood Cell Count (RBC)
- Mean Platelet Volume
- Plateletcrit
- Haematocrit (HCT)
- Mean Cell Haemoglobin (MCH)
- Platelets (PLT)
- Total White Blood Cell Count (WBC)
- Red Cell Dist. Width
Request your FREE RIQAS consultation
Allow our RIQAS consultants to provide your laboratory with a free consultation to demonstrate how RIQAS can consolidate the number of EQA programmes required to cover your test menu, saving your laboratory precious time and money.
Simply fill out the form below to request a consultation today!
CYFRA 21-1 External Quality Assessment
The RIQAS CYFRA 21-1 EQA programme is designed to cover the analysis of CYFRA 21-1 in clinical laboratories when monitoring the response to treatment of cancers such as non-small cell lung carcinoma, cervical, breast and bladder cancer.
- Lyophilised samples
- Monthly reporting
- Testing covers the full range of clinically relevant decision levels
- Submit results and view reports online via RIQAS.net
- 12 month subscription
- Cycle Starts – March 2025
Not accredited to ISO/IEC 17043
| Cat No | Kit Size | Frequency | Parameters | |
|---|---|---|---|---|
| RQ9175 | 12 x 1ml | Monthly | 1 | |
Parameter
- CYFRA 21-1 (Cytokeratin 19)
Please note, product availability may vary country to country.
Related Products
Anti-TSH Receptor External Quality Assessment
The RIQAS Anti-TSH Receptor EQA programme is designed to cover the analysis of Anti-TSH Receptor in clinical laboratories when thyroid dysfunction is suspected.
- Lyophilised samples
- Monthly reporting
- Testing covers the full range of clinically relevant decision levels
- Submit results and view reports online via RIQAS.net
- 12 month subscription
- Cycle Starts – March 2025
Not accredited to ISO/IEC 17043
| Cat No | Kit Size | Frequency | Parameters | |
|---|---|---|---|---|
| RQ9174 | 12 x 1ml | Monthly | 1 | |
Parameter
- Anti-TSH Receptor (TRAb)
Please note, product availability may vary country to country.
Related Products
Immunosuppressant External Quality Assessment
The RIQAS Immunosuppressant EQA programme has been designed to cover the analysis of Immunosuppressants in clinical laboratories. Immunosuppressants are primarily used after transplant operations to prevent the host body from rejecting donor organs.
- Lyophilised samples
- Monthly reporting
- Testing covers the full range of clinically relevant decision levels
- Submit results and view reports online via RIQAS.net
- 12 month subscription
- LC/MS reference values provided enabling participants to compare results to an accurately assigned value
- Cycle Starts – March 2025
Not accredited to ISO/IEC 17043
| Cat No | Kit Size | Frequency | Parameters | |
|---|---|---|---|---|
| RQ9159 | 12 x 2ml | Monthly (1 x 12 month cycle) | 4 | |
Parameters
- Cyclosporin
- Everolimus
- Sirolimus
- Tacrolimus
Please note, product availability may vary country to country.
Related Products
Sweat Testing External Quality Assessment
The RIQAS Sweat Testing EQA programme has been designed to cover the analysis of Sweat Testing in clinical laboratories measuring the concentration of Chloride and Conductivity in sweat, used in the testing of Cystic Fibrosis (CF).
- Liquid ready-to-use samples
- Monthly reporting
- Testing covers the full range of clinically relevant decision levels
- Submit results and view reports online via RIQAS.net
- 12 month subscription
- Cycle Starts – March 2025
Not accredited to ISO/IEC 17043
| Cat No | Kit Size | Frequency | Parameters | |
|---|---|---|---|---|
| RQ9173 | 12 x 2ml | Monthly | 2 | |
Parameter
- Chloride
- Conductivity
Please note, product availability may vary country to country.
CSF External Quality Assessment
The RIQAS Cerebrospinal Fluid EQA programme has been designed to monitor the performance of CSF in clinical laboratories where samples are tested to diagnose a range of medical disorders.
- Liquid ready-to-use samples
- Monthly reporting
- Testing covers the full range of clinically relevant decision levels
- Submit results and view reports online via RIQAS.net
- 12 month subscription
- Cycle Starts – March 2025
Not accredited to ISO/IEC 17043
| Cat No | Kit Size | Frequency | Parameters | |
|---|---|---|---|---|
| RQ9168 | 12 x 3ml | Monthly | 7 | |
Parameters
- Albumin (conc)
- Chloride
- Glucose
- IgG
- Lactate
- Total Protein
- Sodium
Please note, product availability may vary country to country.
Related Products
Ammonia/Ethanol External Quality Assessment
Combining Ammonia and Ethanol in a single RIQAS programme, participants can consolidate their EQA requirements whilst reducing costs. All samples are supplied liquid ready-to-use at the start of the cycle for added convenience and will cover a range of clinically significant concentrations.
- Liquid ready-to-use samples
- Monthly reporting
- Comprehensive yet user friendly reports for quick assessment of performance
- Submit results and view reports online via RIQAS.Net
- Register up to five instruments per programme (volume permitting) at no extra cost for comparative performance assessment
- Accredited to ISO/IEC 17043
- Cycle Starts – September 2025
| Cat No | Kit Size | Frequency | Parameters | |
|---|---|---|---|---|
| RQ9164 | 12 x 2ml | Monthly (1 x 12 month cycle) | 2 | |
Parameters
- Ammonia
- Ethanol
Please note, product availability may vary country to country.
